Company Filing History:
Years Active: 1999
Title: Ann M Goudreau: Innovator in Viral Production Processes
Introduction
Ann M Goudreau is a prominent inventor based in San Diego, California. She has made significant contributions to the field of biotechnology, particularly in the development of methods for producing recombinant viral vectors. Her innovative work has the potential to advance various applications in gene therapy and vaccine development.
Latest Patents
Ann M Goudreau holds a patent for a viral production process. This invention is directed to a method of producing recombinant viral vectors at high titers, incorporating several advancements over existing technologies. The method enhances the production of viruses, especially those encoding exogenous transgenes. Specifically, it describes a high titer serum-free media production method for recombinant replication-defective adenoviruses containing an exogenous transgene. The invention includes methods for preparing microcarriers, seeding bioreactors at high cell density, increasing the infectivity of producer cells, synchronizing the cell cycle of producer cells to increase product yield, and minimizing the negative effects of exogenous transgenes. Additionally, the invention provides producer cells and viruses produced by this process.
Career Highlights
Ann M Goudreau has established herself as a key figure in her field through her innovative research and development efforts. Her work at Canji Inc. has positioned her at the forefront of viral vector technology.
Collaborations
Throughout her career, Ann has collaborated with notable colleagues, including Daniel D Giroux and Muralidhara Ramachandra. These collaborations have further enriched her research and contributed to the advancement of viral production processes.
Conclusion
Ann M Goudreau's contributions to the field of biotechnology, particularly in viral production processes, highlight her innovative spirit and dedication to advancing science. Her work continues to pave the way for future developments in gene therapy and related fields.